Wednesday, January 16, 2013

• This Is No Vioxx 2.0at Motley Fool (Wed, Jan 16)
• Merck Shares Are Cheap And Worth Buying Nowat Seeking Alpha (Wed, Jan 16)
• Pharma's BRIC Buildingat Motley Fool (Wed, Jan 16)
• 1 Spinoff That Investors Forgotat Motley Fool (Wed, Jan 16)
• Pfizer: Buy, Sell Or Hold?at Seeking Alpha (Wed, Jan 16)
• Big Pharma's Animal Instinctat Motley Fool (Wed, Jan 16)

Tuesday, January 15, 2013

• Aura Migraines Linked to Heart Attack Risk for Womenat Bloomberg (Tue, Jan 15)
• Will Pharma Fix Health Care?at Motley Fool (Tue, Jan 15)
• Invest In Demographicsat Motley Fool (Tue, Jan 15)
• Is This the Softer Side of Big Pharma?at Motley Fool (Tue, Jan 15)
• Will Alkermes' Antipsychotic ALKS-3831 Become Another Tredaptive?at Forbes (Tue, Jan 15)

Monday, January 14, 2013

• Companies For The Conservative Investorat Motley Fool (Mon, Jan 14)
• Merck to Stop Selling TredaptiveZacks (Mon, Jan 14)
• This Week in Biotechat Motley Fool (Mon, Jan 14)
• The Battle for Diabetes Dominanceat Motley Fool (Mon, Jan 14)

Sunday, January 13, 2013

• The Soft Underbelly of ZIOPHARM Oncologyat Motley Fool (Sun, Jan 13)
• 1 Great Dividend You Can Buy Right Nowat Motley Fool (Sun, Jan 13)
• These 4 Dow Companies Are on Their Way Upat Motley Fool (Sun, Jan 13)

Saturday, January 12, 2013

• The Stocks Wall Street Was Buzzing Aboutat CNBC (Sat, Jan 12)
• Top 3 Dow Stocks This Weekat Motley Fool (Sat, Jan 12)

Friday, January 11, 2013

• Merck Pulls the Plugat Motley Fool (Fri, Jan 11)
• The Flu Shot's Not A Great Vaccine, But You Should Get One Anywayat Forbes (Fri, Jan 11)
• Merck & Co Inc (MRK): Today's Featured Drugs Winnerat TheStreet (Fri, Jan 11)
• Merck Halts Sales of Cholesterol Drug Outside U.S.at Bloomberg (Fri, Jan 11)
• What Merck Told Doctors About Tredaptive Before It Stopped Selling Itat Forbes (Fri, Jan 11)

Add MRK News to My Yahoo!